WallStreetZenWallStreetZen

NASDAQ: FRLN
Freeline Therapeutics Holdings PLC Stock Ownership - Who owns Freeline Therapeutics Holdings?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Freeline Therapeutics Holdings PLC insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when FRLN insiders and whales buy or sell their stock.

FRLN Shareholders

What type of owners hold Freeline Therapeutics Holdings PLC stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Syncona Portfolio Ltd33.78%21,997,620$55.21MInstitution
Chi Advisors LLC7.26%4,729,419$11.87MInstitution
Eventide Asset Management LLC7.22%4,702,641$11.80MInstitution
Tfg Asset Management GP Ltd6.14%4,000,000$10.04MInstitution
Ubs Group Ag0.77%500,000$1.26MInstitution
Renaissance Technologies LLC0.35%230,600$578.81kInstitution
Morgan Stanley0.29%189,503$475.65kInstitution
Millennium Management LLC0.25%162,214$407.16kInstitution
Citadel Advisors LLC0.18%116,795$293.16kInstitution
Harbor Capital Advisors Inc0.17%107,731$270.40kInstitution

1 of 2

FRLN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
FRLN56.60%0.00%
LIXT8.87%91.13%Net Buying
SGTX73.58%26.42%
GTBP13.25%2.15%Net BuyingNet Buying
AMTI43.73%56.27%Net Buying
View Top Biotech Stocks

Freeline Therapeutics Holdings Stock Ownership FAQ

Who owns Freeline Therapeutics Holdings?

Freeline Therapeutics Holdings (NASDAQ: FRLN) is owned by 56.60% institutional shareholders, 0.00% Freeline Therapeutics Holdings insiders, and 43.40% retail investors. Syncona Portfolio Ltd is the largest individual Freeline Therapeutics Holdings shareholder, owning 22.00M shares representing 33.78% of the company. Syncona Portfolio Ltd's Freeline Therapeutics Holdings shares are currently valued at $55.21M.

If you're new to stock investing, here's how to buy Freeline Therapeutics Holdings stock.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.